» Articles » PMID: 33536424

Identification of 38 Novel Loci for Systemic Lupus Erythematosus and Genetic Heterogeneity Between Ancestral Groups

Abstract

Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability, shows differences in prevalence, severity and age of onset among different ancestral groups. Previous genetic studies have focused more on European populations, which appear to be the least affected. Consequently, the genetic variations that underlie the commonalities, differences and treatment options in SLE among ancestral groups have not been well elucidated. To address this, we undertake a genome-wide association study, increasing the sample size of Chinese populations to the level of existing European studies. Thirty-eight novel SLE-associated loci and incomplete sharing of genetic architecture are identified. In addition to the human leukocyte antigen (HLA) region, nine disease loci show clear ancestral differences and implicate antibody production as a potential mechanism for differences in disease manifestation. Polygenic risk scores perform significantly better when trained on ancestry-matched data sets. These analyses help to reveal the genetic basis for disparities in SLE among ancestral groups.

Citing Articles

Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.

Xu Y, Wang Z, Jia T, Liang S PLoS One. 2025; 20(1):e0316481.

PMID: 39823480 PMC: 11741580. DOI: 10.1371/journal.pone.0316481.


Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population.

Cui Q, Tan W, Song B, Peng R, Wang L, Dorajoo R Leukemia. 2024; 39(3):694-702.

PMID: 39707004 DOI: 10.1038/s41375-024-02503-4.


Breaking barriers: advancing cellular therapies in autoimmune disease management.

Fu Y, Feng C, Qin S, Xing Z, Liu C, Liu Z Front Immunol. 2024; 15:1503099.

PMID: 39676874 PMC: 11638217. DOI: 10.3389/fimmu.2024.1503099.


Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus.

Charras A, Hiraki L, Lewandowski L, Hedrich C Curr Opin Rheumatol. 2024; 37(2):149-163.

PMID: 39660463 PMC: 11789615. DOI: 10.1097/BOR.0000000000001072.


Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases.

Tian C, Zhang Y, Tong Y, Kock K, Sim D, Liu F Nat Genet. 2024; 56(12):2739-2752.

PMID: 39627432 PMC: 11631754. DOI: 10.1038/s41588-024-02019-8.


References
1.
Isenberg D, Gordon C, Licu D, Copt S, Rossi C, Wofsy D . Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial). Ann Rheum Dis. 2014; 74(11):2006-15. PMC: 4680140. DOI: 10.1136/annrheumdis-2013-205067. View

2.
Li P, Chang Y, Shek K, Lau Y . Lack of association of TYK2 gene polymorphisms in Chinese patients with systemic lupus erythematosus. J Rheumatol. 2011; 38(1):177-8. DOI: 10.3899/jrheum.100424. View

3.
Nei M . Analysis of gene diversity in subdivided populations. Proc Natl Acad Sci U S A. 1973; 70(12):3321-3. PMC: 427228. DOI: 10.1073/pnas.70.12.3321. View

4.
Westra H, Peters M, Esko T, Yaghootkar H, Schurmann C, Kettunen J . Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013; 45(10):1238-1243. PMC: 3991562. DOI: 10.1038/ng.2756. View

5.
Harley J, Chen X, Pujato M, Miller D, Maddox A, Forney C . Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 2018; 50(5):699-707. PMC: 6022759. DOI: 10.1038/s41588-018-0102-3. View